Evolus, Inc.
For the period ended Aug 5, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 5, 2026 · Filed Aug 5, 2026
Use the contents to explore the available documents and sections.
EOLS$6.81+0.1%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Adjusted EBITDA and Adjusted EBITDA Margin
Adjusted EBITDA and Adjusted EBITDA Margin
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| GAAP net loss | $(8,052) | $(17,142) | (18,726) | (36,034) |
| Adjustments: | ||||
| Income tax (benefit) expense | (154) | 53 | 102 | 125 |
| Interest income and expense | 3,876 | 6,728 | 7,566 | 10,433 |
| Depreciation and amortization | 1,529 | 932 | 3,067 | 1,756 |
| Amortization of distribution right intangible assets | 807 | 806 | 1,615 | 1,545 |
| Revaluation of contingent royalty obligation | 1,250 | (3,914) | 1,236 | (1,763) |
| Stock-based compensation: | ||||
| Included in selling, general and administrative | 5,226 | 4,346 | 9,976 | 10,095 |
| Included in research and development | 396 | 142 | 762 | 321 |
| Other income (expense), net | (213) | 151 | (333) | 94 |
| Adjusted EBITDA | $4,665 | $(7,898) | $5,265 | $(13,428) |
| Adjusted EBITDA margin | 5.5% | (11.4)% | 3.3% | (9.7)% |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.